Health X Platform Ltd

Q3 FY26Healthcare Services

Health X Platform Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹301

Market cap₹977 Cr

P/E508.6

Updated23 Aug 2026

Read5 min read

The short version

Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability. Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin. - SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency. - The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years. - PAT turned positive at Rs.

From Health X Platform Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability.
SastaSundar B2C business is expected to grow around 100% year-on-year from this year to next.
January to March is expected to be one of the best quarters, with recent growth trends positive.
Expansion plans include new warehouses in Lucknow, Udaipur, and capacity doubling in existing facilities to support growth across Eastern, Northern, and North-Eastern India.
The JITO generic brand is projected to significantly increase revenue and gross margin by tapping into a rapidly growing generic medicine market.

2 more points management made on revenue & sales performance

Profitability & Margins

Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin.
SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency.
The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years.
PAT turned positive at Rs. 11 crores in 9-month FY26 vs. loss of Rs. 151 crores in the previous year, supported by improved operating efficiency and other income.

2 more points management made on profitability & margins

See what Health X Platform Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Investing ~Rs. 10 crores in West Bengal for an additional 80,000 sq ft warehouse capacity (completion in ~6 months).
Planning a new warehouse in Noida; timeline about 1.5 years; also expansions in Guwahati, Lucknow, Udaipur (2-year horizon).
Allocated Rs. 25 crores annually for AI and technology development for both SastaSundar and Retailer Shakti platforms.
Rs. 150 crores earmarked for new technology building, with Rs. 50-60 crores already spent; remaining to be funded from treasury income over next 2-3 years.
Rs. 10 crores invested in Retail Air, an AI-driven SaaS platform for retailers, to be launched in 3-4 months.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Chandan Healthca₹590 Cr

Rev 1Mar 3

2Aster DM Quality₹66.2K Cr

Rev 2Mar 1

3₹1.8K Cr

Rev 2Mar 2

4₹649 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There is no explicit mention of any ongoing or planned fundraising through debt or equity in the provided pages.
The management emphasizes strong capital efficiency and treasury income supporting growth, indicating a focus on self-sustained funding.
The company has significant cash reserves (~Rs. 500 crores combined treasury as of March 2025) and aims to use these funds for growth.
A merger and demerger process is planned for the next financial year, but no direct reference to raising funds via this route.

2 more points management made on fundraising & capital structure

See what Health X Platform Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The document does not explicitly mention any current or expected order book or pending orders for SastaSundar Ventures Limited. However, relevant insights related to order flow and growth include: - Retailer Shakti guarantees next-day delivery, enabling retailers to reduce inventory from 40 days to 10 days. - The company receives 100% orders through digital channels; over 50% via the app, and the rest via HealthBuddy service centers. - Q3 FY26 saw a 10% quarter-on-quarter growth, with confidence expressed in sustaining 30% CAGR over the next 5-10 years for Retailer Shakti.

2 more points management made on order book & pipeline

Health X Platform Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹346 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Health X Platform Ltd's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Health X Platform Ltd Q3 FY26 results?

What is Health X Platform Ltd share price analysis?

Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.

Is Health X Platform Ltd planning capital expenditure?

Investing ~Rs.

Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.